Assessment of pharmaceutical agents for removing cadmium from humans using chemical speciation models
- 31 October 1984
- journal article
- Published by Elsevier in Inorganica Chimica Acta
- Vol. 93 (2) , 93-100
- https://doi.org/10.1016/s0020-1693(00)87894-9
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion, and distribution of cadmiumToxicology and Applied Pharmacology, 1981
- Biliary excretion of cadmium in rat. IV. Mobilization of cadmium from metallothionein by 2,3‐dimercaptopropanolJournal of Toxicology and Environmental Health, 1980
- Biliary excretion of cadmium in rat. III. Effects of chelating agents and change in intracellular thiol content on biliary transport and tissue distribution of cadmiumJournal of Toxicology and Environmental Health, 1980
- TREATMENT OF LEAD POISONING BY 2,3-DIMERCAPTOSUCCINIC ACIDThe Lancet, 1978
- Meso-dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoningJournal of Pharmacy and Pharmacology, 1976
- THE EFFECTS OF DIMERCAPTOSUCCINIC ACID ON THE EXCRETION AND DISTRIBUTION OF MERCURY IN RATS AND MICE TREATED WITH MERCURIC CHLORIDE AND METHYLMERCURY CHLORIDEBritish Journal of Pharmacology, 1976
- Meso-dimercaptosuccinic acid, a chelating agent for the treatment of mercury poisoningJournal of Pharmacy and Pharmacology, 1975
- Selective Accumulation of Cd115 by Cortex of Rat Kidney.Experimental Biology and Medicine, 1957
- Dimercaprol (2, 3‐Dimercaptopropanol) in Chronic Cadmium Poisoning.Acta Pharmacologica et Toxicologica, 1955
- British Anti-Lewisite (BAL)Nature, 1945